SANDUPHQ.BO
Price:
$56.11
Market Cap:
$542.08M
Sandu Pharmaceuticals Ltd. engages in the manufacture and marketing of Ayurvedic medicines. It offers its products under the Berbenteron suspension, Berbenteron tablets, Bilagyl, Debix, Elegance Oil, Ephenin, Haemol Forte, Madiphal Rasayan, Osteon D, Pregutero, Sarak, Shatari, Stresan, Jaundex, Vanari Kalpa, Vimfix, Whoopin and Pentazyme brands. The company was founded on May 10, 1899 and is headquartered in Mumbai, India.
Industry
Medical - Pharmaceuticals
IPO Date
2002-01-03
Stock Exchange
BSE
Ticker
SANDUPHQ.BO
According to Sandu Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 29.85. This represents a change of -26.77% compared to the average of 40.76 of the last 4 quarters.
The mean historical PE Ratio of Sandu Pharmaceuticals Limited over the last ten years is 21.93. The current 29.85 PE Ratio has changed 13.51% with respect to the historical average. Over the past ten years (40 quarters), SANDUPHQ.BO's PE Ratio was at its highest in in the September 2015 quarter at 468.23. The PE Ratio was at its lowest in in the June 2017 quarter at -7.37.
Average
21.93
Median
32.36
Minimum
-50.61
Maximum
39.20
Discovering the peaks and valleys of Sandu Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 166.02%
Maximum Annual PE Ratio = 39.20
Minimum Annual Increase = -255.96%
Minimum Annual PE Ratio = -50.61
Year | PE Ratio | Change |
---|---|---|
2024 | 39.20 | 21.49% |
2023 | 32.27 | -8.41% |
2022 | 35.23 | 71.67% |
2021 | 20.52 | 77.66% |
2020 | 11.55 | -50.28% |
2019 | 23.23 | -38.60% |
2018 | 37.83 | -174.75% |
2017 | -50.61 | -255.96% |
2016 | 32.45 | -13.83% |
2015 | 37.66 | 166.02% |
The current PE Ratio of Sandu Pharmaceuticals Limited (SANDUPHQ.BO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
35.56
5-year avg
27.75
10-year avg
21.93
Sandu Pharmaceuticals Limited’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sandu Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sandu Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sandu Pharmaceuticals Limited's PE Ratio?
How is the PE Ratio calculated for Sandu Pharmaceuticals Limited (SANDUPHQ.BO)?
What is the highest PE Ratio for Sandu Pharmaceuticals Limited (SANDUPHQ.BO)?
What is the 3-year average PE Ratio for Sandu Pharmaceuticals Limited (SANDUPHQ.BO)?
What is the 5-year average PE Ratio for Sandu Pharmaceuticals Limited (SANDUPHQ.BO)?
How does the current PE Ratio for Sandu Pharmaceuticals Limited (SANDUPHQ.BO) compare to its historical average?